Dimensional Fund Advisors LP Plus Therapeutics, Inc. Transaction History

Dimensional Fund Advisors LP

  • $403 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$0.87 - $1.32 $22,191 - $33,669
-25,507 Closed
0 $0
Q3 2021

Nov 12, 2021
SELL
$1.83 - $2.46 $78,549 - $105,590
-42,923 Reduced 62.73%
25,507 $49,000
Q2 2021

Aug 12, 2021
BUY
$2.0 - $2.89 $136,860 - $197,762
68,430 New
68,430 $175,000

About PLUS THERAPEUTICS, INC.

PSTV Quotes by TradingView
  • Ticker PSTV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,601,400
  • Market Cap $40M
  • Description
  • Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases. Its lead drug candidate is Rhenium-186 NanoLiposome, a patented radiotherapy that targets central nervous system cancers, including recurrent glioblastoma, lep...
More about PSTV
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email